Cargando…
Establishing Newborn Screening for SCID in the USA; Experience in California †
Newborn screening for severe combined immunodeficiency (SCID) has developed from the realization that infants affected with SCID require prompt diagnosis and treatment to avoid fatal infectious complications. Screening DNA from infant dried blood spots for T-cell receptor excision circles (TRECs), b...
Autores principales: | Puck, Jennifer M., Gennery, Andrew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628983/ https://www.ncbi.nlm.nih.gov/pubmed/34842619 http://dx.doi.org/10.3390/ijns7040072 |
Ejemplares similares
-
Newborn Screening for SCID Identifies Patients with Ataxia Telangiectasia
por: Mallott, Jacob, et al.
Publicado: (2012) -
Newborn Screening for SCID. Experience in Spain (Catalonia)
por: Argudo-Ramírez, Ana, et al.
Publicado: (2021) -
Neonatal Screening for SCID: The French Experience
por: Audrain, Marie, et al.
Publicado: (2021) -
Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program
por: Blom, Maartje, et al.
Publicado: (2018) -
Universal Newborn Screening for Severe Combined Immunodeficiency (SCID)
por: van der Burg, Mirjam, et al.
Publicado: (2019)